Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-05 Purchase |
2023-10-06 07:38 am |
Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer |
22,727 | $22 | $499,994 | 189,380 (Direct) |
View |
| 2022-10-25 Purchase |
2022-10-26 6:21 pm |
Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer |
142,857 | $10.5 | $1,499,999 | 166,653 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-03 8:28 pm |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer |
6,177 | $148.5 | $917,285 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-05 Exercise |
2025-01-07 8:49 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer |
4,250 | $0 | 327,202 (Direct) |
View |
| 2025-01-05 Tax Withholding |
2025-01-07 8:49 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer |
2,561 | $38.64 | 327,202 (Direct) |
View |
| 2025-01-05 Option Award |
2025-01-07 8:49 pm |
N/A 2035-01-05 |
Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer |
121,000 | $0 | 327,202 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 8:07 pm |
N/A 2034-01-02 |
Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer |
96,250 | $0 | 96,250 (Direct) |
View |
| 2023-11-02 Option Award |
2023-11-06 8:34 pm |
N/A 2033-11-02 |
Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer |
78,750 | $0 | 78,750 (Direct) |
View |
| 2022-10-03 Other |
2022-10-05 5:36 pm |
N/A 2032-01-07 |
Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer |
34,838 | $0 | 358,634 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 5:36 pm |
N/A 2032-01-07 |
Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer |
13,000 | $0 | 358,634 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 5:36 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer |
13,000 | $6.37 | 358,634 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-05 5:36 pm |
N/A 2032-10-04 |
Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer |
300,000 | $0 | 358,634 (Direct) |
View |
| 2022-10-03 Tax Withholding |
2022-10-05 5:36 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Buten Matthew Chief Financial Officer |
11,042 | $7.5 | 358,634 (Direct) |
View |
Ownership |
2022-09-28 8:51 pm |
N/A N/A |
Biohaven Ltd. | BHVN | Buten Matthew Treasurer |
0 | $0 | 0 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 9:19 pm |
N/A 2032-01-07 |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer |
26,000 | $0 | 26,000 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-04 9:30 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer |
12,500 | $0 | 43,677 (Direct) |
View |
| 2021-12-31 Tax Withholding |
2022-01-04 9:30 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer |
6,323 | $137.81 | 43,677 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-14 8:52 pm |
N/A N/A |
Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Officer |
50,000 | $0 | 50,000 (Direct) |
View |